Organization
Eli Lilly and Co, Indianapolis, United States
2 abstracts
Abstract
A PHASE 2 STUDY OF MONTHLY SUBCUTANEOUS LY2127399 (AN ANTI-BAFF MONOCLONAL ANTIBODY) IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS Org: Stanford University, Palo Alto, Inland Rheumatology, Upland, United States, Poznan University of Medical Sciences, Poznan, Poland, Eli Lilly and Co, Indianapolis, United States,
Abstract
A PHASE 2 TRIAL OF INTRAVENOUS LY2127399, AN ANTI-BAFF MONOCLONAL ANTIBODY, IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSE TO TNF-ALPHA INHIBITORS Org: Eli Lilly and Co, Indianapolis, United States, Desert Medical Advances, Palm Desert,